Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

The standard of care for patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancer is endocrine therapy. Endocrine agents, including aromatase inhibitors, tamoxifen, and fulvestrant, are often administered alone as first line treatment and...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliaccio, Ilenia, Malorni, Luca, Hart, Christopher D, Guarducci, Cristina, Di Leo, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350905/
https://www.ncbi.nlm.nih.gov/pubmed/25857348
http://dx.doi.org/10.1186/s12916-015-0280-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350905/
https://www.ncbi.nlm.nih.gov/pubmed/25857348
http://dx.doi.org/10.1186/s12916-015-0280-0

Ejemplares similares